Literature DB >> 34845656

Functional SLC6A3 polymorphisms differentially affect autism spectrum disorder severity: a study on Indian subjects.

Sharmistha Saha1, Mahasweta Chatterjee1, Sayanti Shom1, Swagata Sinha1, Kanchan Mukhopadhyay2.   

Abstract

Imbalance in dopamine (DA) signaling is proposed to play a potential role in the etiology of Autism spectrum disorder (ASD) since, as a neuromodulator, DA regulates executive function, motor activity, social peering, attention as well as perception and subjects with ASD often exhibit deficit in these traits. Level of DA in the synaptic cleft is maintained by dopamine transporter (DAT) and hence, to identify the role of DAT in ASD, we have analyzed four functional genetic variants, rs28363170, rs3836790, rs2652511, rs27072, in nuclear families with ASD probands. Subjects were diagnosed based on Diagnostic and Statistical Manual for Mental Disorders and trait severity was assessed by Childhood Autism Rating Scale 2-Standard test. Informed written consent was obtained from the parents/care givers before recruitment followed by collection of peripheral blood for genomic DNA isolation. Target sites were investigated by PCR-based methods and data obtained was analyzed by population- as well as family-based statistical methods. Case-control analysis revealed significant higher frequencies of 9 repeat (9R) and 5 repeat (5R) alleles of rs28363170 and rs3836790 respectively in the ASD probands. Family-based analysis showed statistically significant higher paternal transmission of rs28363170 9R and rs2652511 T alleles. In the presence of rs28363170 9R, rs27072 C, rs3836790 6R6R, and rs2652511 CC variants, trait scores were higher. Studied variants showed independent as well as interactive effects, which varied based on gender of the probands. We infer that altered DA availability mediated through DAT may affect autistic traits warranting further in depth investigation in the field.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ASD; Autistic traits; Dopamine; Gene variants; SLC6A3

Mesh:

Substances:

Year:  2021        PMID: 34845656     DOI: 10.1007/s11011-021-00876-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  35 in total

1.  Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Authors:  Anne-Claude Bédard; Kurt P Schulz; Edwin H Cook; Jin Fan; Suzanne M Clerkin; Iliyan Ivanov; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

2.  Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.

Authors:  Lucas A de Azeredo; Diego L Rovaris; Nina R Mota; Evelise R Polina; Francine Z Marques; Verônica Contini; Eduardo S Vitola; Paulo Belmonte-de-Abreu; Luis A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-01       Impact factor: 5.270

3.  Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.

Authors:  Gabriella E DiCarlo; Jenny I Aguilar; Heinrich Jg Matthies; Fiona E Harrison; Kyle E Bundschuh; Alyssa West; Parastoo Hashemi; Freja Herborg; Mattias Rickhag; Hao Chen; Ulrik Gether; Mark T Wallace; Aurelio Galli
Journal:  J Clin Invest       Date:  2019-05-16       Impact factor: 14.808

4.  Dopamine transporter (DAT1) VNTR polymorphism and alcoholism in two culturally different populations of south India.

Authors:  Lakkakula V K S Bhaskar; Kumarasamy Thangaraj; Samiksha Wasnik; Lalji Singh; Vadlamudi Raghavendra Rao
Journal:  Am J Addict       Date:  2012-05-16

5.  Pharmacological Intervention in Children with Autism Spectrum Disorder with Standard Supportive Therapies Significantly Improves Core Signs and Symptoms: A Single-Center, Retrospective Case Series.

Authors:  Hamza A Alsayouf; Haitham Talo; Marisa L Biddappa; Mohammad Qasaymeh; Shadi Qasem; Emily De Los Reyes
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-16       Impact factor: 2.570

6.  Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.

Authors:  Frank Dudbridge
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

7.  Testing genetic modifiers of behavior and response to atomoxetine in autism spectrum disorder with ADHD.

Authors:  Elizabeth S Barrie; Julia K Pinsonneault; Wolfgang Sadee; Jill A Hollway; Benjamin L Handen; Tristram Smith; L Eugene Arnold; Eric Butter; Emily Hansen-Kiss; Gail E Herman; Michael G Aman
Journal:  J Dev Phys Disabil       Date:  2018-03-05

8.  A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy.

Authors:  Keeley-Joanne Brookes; Jon Mill; Camilla Guindalini; Sarah Curran; Xiaohui Xu; Jo Knight; Chih-Ken Chen; Yu-Shu Huang; Vaheshta Sethna; Eric Taylor; Wai Chen; Gerome Breen; Philip Asherson
Journal:  Arch Gen Psychiatry       Date:  2006-01

9.  SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.

Authors:  E Bowton; C Saunders; I A Reddy; N G Campbell; P J Hamilton; L K Henry; H Coon; D Sakrikar; J M Veenstra-VanderWeele; R D Blakely; J Sutcliffe; H J G Matthies; K Erreger; A Galli
Journal:  Transl Psychiatry       Date:  2014-10-14       Impact factor: 6.222

Review 10.  Autism risk factors: genes, environment, and gene-environment interactions.

Authors:  Pauline Chaste; Marion Leboyer
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.